Cargando…
Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724826/ https://www.ncbi.nlm.nih.gov/pubmed/34983103 http://dx.doi.org/10.4168/aair.2022.14.1.5 |
| _version_ | 1784625992519647232 |
|---|---|
| author | Kim, Byeong-Gon Park, Moo Kyun |
| author_facet | Kim, Byeong-Gon Park, Moo Kyun |
| author_sort | Kim, Byeong-Gon |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8724826 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87248262022-01-12 Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases Kim, Byeong-Gon Park, Moo Kyun Allergy Asthma Immunol Res Editorial The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease 2021-12-29 /pmc/articles/PMC8724826/ /pubmed/34983103 http://dx.doi.org/10.4168/aair.2022.14.1.5 Text en Copyright © 2022 The Korean Academy of Asthma, Allergy and Clinical Immunology • The Korean Academy of Pediatric Allergy and Respiratory Disease https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Kim, Byeong-Gon Park, Moo Kyun Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title | Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title_full | Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title_fullStr | Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title_full_unstemmed | Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title_short | Interleukin-17 Can Be the Target of Novel Treatment Strategies for Particulate Matter–Induced Allergic Diseases |
| title_sort | interleukin-17 can be the target of novel treatment strategies for particulate matter–induced allergic diseases |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8724826/ https://www.ncbi.nlm.nih.gov/pubmed/34983103 http://dx.doi.org/10.4168/aair.2022.14.1.5 |
| work_keys_str_mv | AT kimbyeonggon interleukin17canbethetargetofnoveltreatmentstrategiesforparticulatematterinducedallergicdiseases AT parkmookyun interleukin17canbethetargetofnoveltreatmentstrategiesforparticulatematterinducedallergicdiseases |